Abstract
Introduction. Viral infections during pregnancy have always been considered to cause complications and adverse events and birth defects during pregnancy. In particular, we do not have any therapeutic or preventive tools aimed at protecting the mother and fetus during the gestational period during pandemics. Methods. The studies were identified by using the PubMed database published until 30 April 2021. The search was performed by using the following keywords: viral infection, SARS-CoV-2, COVID-19, vaccine, pregnancy, gestational period, pandemics, vaccination, complication, adverse events, drugs. Results. It has been reported that viral infections are considered to cause complications and adverse events during pregnancy. In this regard, pregnancy is associated with higher mortality rates and complications during viral infections. In fact, maternal immunization represents a unique approach to protect newborns from several infectious diseases. Conclusion. European Board and College of Obstetrics and Gynecology (EBCOG) and International public health institutions (WHO, CDC) report the recommendations about the use of vaccines during pregnancy.
Highlights
Viral infections during pregnancy have always been considered to cause complications and adverse events and birth defects during pregnancy
The pregnant woman will undergo a series of immune changes that can increase the susceptibility of the mother to infectious diseases [45,46]
It is likely that SARS-CoV-2 vaccination could prevent tens of thousands of postoperative deaths linked to COVID-19, especially in particular situations such as pregnancy
Summary
Viral infections during pregnancy have always been considered to cause complications and adverse events and birth defects during pregnancy. It is conceivable that most pregnant patients infected with the COVID-19 virus have mild or moderate flu symptoms. More serious symptoms, such as pneumonia, seem to be more common in the elderly population or in subjects suffering from chronic diseases. Pregnant women are considered the most vulnerable, in particular in the first trimester during embryogenesis and for symptomatic patients. This is because, there are no data relating to greater risk, not all the potential effects that the virus could cause on the body of a pregnant woman are known. COVID 2021, 1 describe the therapeutic or preventive tools for the mother and fetus during the gestational period and, in particular during the COVID-19 pandemic
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
